<DOC>
	<DOCNO>NCT01732991</DOCNO>
	<brief_summary>The PVP Greenlight laser 180W become potential therapeutic alternative treatment benign prostatic hypertrophy ( BPH ) recommend . The PVP create prostatic box vaporization prostatic tissue BPH . The underlying prostatic tissue site ischemic necrosis secondary thermal effect proximity PVP . We intend measure prostatic MRI contrast-enhanced ultrasound necrosis .</brief_summary>
	<brief_title>Assessing Impact PVP With Greenlight Laser Using Prostatic MRI Contrast-enhanced Ultrasound</brief_title>
	<detailed_description>The laser PVP optical fiber fire side carry vaporization next prostatic tissue necrosis underlie prostatic tissue corresponds postoperative inflammatory area . One side effect technique irritative syndrome may involve urinary frequency , urgency burn urination approximately 10 20 % 1 month . The current literature report neither analysis underlying inflammatory necrotic area prostatic vaporized tissue , analysis urinary irritative sign post-laser PVP . Progresses field functional ultrasound image allow u consider study evolution underlie necrotic area devoid micro-vascularisation effect PVP laser . The parallel result MRI ( radiological technique reference ) period would help support experimental result prostatic contrast-enhanced ultrasound .</detailed_description>
	<mesh_term>Hypertrophy</mesh_term>
	<mesh_term>Prostatic Hyperplasia</mesh_term>
	<criteria>Patient 40 year old without upper age limit Informed orally write , sign consent match research Patient benign prostatic hypertrophy require surgical treatment PVP Person affiliate social security system Contraindications MRI patient : ocular metallic foreign object electronic medical device implant irremovable way ( pacemaker , neurostimulator , cochlear implant ... ) metallic heart valve , old heart valves specially absolute contraindication risk dysfunction vascular clip implant formerly brain aneurysm Allergy Gadolinium Contraindications contrast medium Sonovue : Hypersensitivity hexafluorinated sulphur component Sonovue Recent acute coronary syndrome ( within 6 month intervention ) Unstable ischemic heart disease ( myocardial infarction form evolve , typical angina rest previous month ) Significant worsen cardiac symptom pre anaesthesia consultation intervention Recent intervention ( le 6 month ) coronary artery factor suggest clinical instability ( change ECG , change clinical biological parameter ) Acute heart failure heart failure stage III IV Severe arrhythmia Rightleft shunt Acute endocarditis Valve prothesis Severe pulmonary hypertension ( pulmonary artery pressure &gt; 90mmHg ) Systemic hypertension uncontrolled Respiratory distress syndrome Prostatic biopsy &lt; 30 day anal pathology Patient prostate cancer Patient urinary infection Patient preoperative urinary catheter Patient contraindication surgery Adult patient legal protection measure</criteria>
	<gender>Male</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>August 2015</verification_date>
	<keyword>Prostatic Hypertrophy , Benign</keyword>
	<keyword>Greenlight laser</keyword>
	<keyword>Prostatic photovaporization</keyword>
	<keyword>Prostatic MRI</keyword>
	<keyword>Prostatic contrast-enhanced ultrasound</keyword>
	<keyword>Urinary irritative sign</keyword>
	<keyword>Postoperative necrotic area</keyword>
</DOC>